Ascendis Pharma A/S (ASND) Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and Takeda Pharmaceutical (NYSE:TAK) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Do analysts recommend ASND or TAK?

Ascendis Pharma A/S presently has a consensus target price of $244.36, suggesting a potential upside of 24.41%. Given Ascendis Pharma A/S's stronger consensus rating and higher possible upside, equities analysts plainly believe Ascendis Pharma A/S is more favorable than Takeda Pharmaceutical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendis Pharma A/S	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00
Takeda Pharmaceutical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more volatility and risk, ASND or TAK?

Ascendis Pharma A/S has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Comparatively, Takeda Pharmaceutical has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500.

Is ASND or TAK more profitable?

Takeda Pharmaceutical has a net margin of 3.20% compared to Ascendis Pharma A/S's net margin of -54.94%. Takeda Pharmaceutical's return on equity of 10.50% beat Ascendis Pharma A/S's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ascendis Pharma A/S	-54.94%	N/A	-24.31%
Takeda Pharmaceutical	3.20%	10.50%	5.10%

Does the media refer more to ASND or TAK?

In the previous week, Ascendis Pharma A/S and Ascendis Pharma A/S both had 10 articles in the media. Ascendis Pharma A/S's average media sentiment score of 1.27 beat Takeda Pharmaceutical's score of 0.42 indicating that Ascendis Pharma A/S is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ascendis Pharma A/S	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Takeda Pharmaceutical	2 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders hold more shares of ASND or TAK?

9.2% of Takeda Pharmaceutical shares are owned by institutional investors. 40.0% of Ascendis Pharma A/S shares are owned by insiders. Comparatively, 0.0% of Takeda Pharmaceutical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Which has preferable valuation and earnings, ASND or TAK?

Takeda Pharmaceutical has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Takeda Pharmaceutical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendis Pharma A/S	$490.75M	24.50	-$409.12M	-$5.16	-38.07
Takeda Pharmaceutical	$30.09B	1.60	$712.33M	$0.30	50.35

Summary

Takeda Pharmaceutical beats Ascendis Pharma A/S on 8 of the 15 factors compared between the two stocks.